Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma

Cancer immunology research

Volumn 2, Issue 11, 2014, Pages 1051-1058

  Bajor, David L ^a   Xu, Xiaowei ^a   Torigian, Drew A ^a   Mick, Rosemarie ^a   Garcia, Laura R ^a   Richman, Lee P ^a   Desmarais, Cindy ^a   Nathanson, Katherine L ^a   Schuchter, Lynn M ^a   Kalos, Michael ^a   Vonderheide, Robert H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; ANTINEOPLASTIC AGENTS; CP-870,893;

CASE REPORT; CELL SEPARATION; CLINICAL TRIAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGY; MELANOMA; METASTASECTOMY; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; REMISSION INDUCTION; SKIN NEOPLASMS; TUMOR MICROENVIRONMENT;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; ANTINEOPLASTIC AGENTS; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; MELANOMA; METASTASECTOMY; MIDDLE AGED; REMISSION INDUCTION; SKIN NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84922254940     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0154     Document Type: Article

References (0)